QA: Blueprint Medicines Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597264_2022_Blueprint_Medicines_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597264, Blueprint Medicines Corp

  xvar xval
0 AssetsCurrent 554,025,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 30,700,000
3 remainder_Assets 667,500,000
4 LiabilitiesCurrent 149,765,000
5 LiabilitiesNoncurrent 131,725,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 105,479,000
8 SellingGeneralAndAdministrativeExpense 360,397,312
9 ResearchAndDevelopmentExpense 1,097,421,642
10 remainder_Expenses 59,521,997
11 remainder_Revenues 550,927,124
12 remainder_NetIncome -4,052,465
13 remainder_ComprehensiveNetIncome 418,160
  yvar yval
0 Assets 1,252,225,000
1 Liabilities 281,490,000
2 Expenses 1,622,819,951
3 Revenues 550,927,124
4 StockholdersEquity 970,735,000
5 NetIncome -1,075,945,292
6 ComprehensiveNetIncome -1,075,736,212
7 BaseVar 1,855,966,350
8 EconomicCapitalRatiobeforeLimitedLiability 1.36
9 EconomicCapitalRatio 2.57

Edgar->Model Mapping

Feature Distribution

Change over Time